Secukinumab-induced Oral Lichen Planus: A Report of Case and Review of Literature

dc.contributor.authorDaye, Munise
dc.contributor.authorTemiz, Selami Aykut
dc.contributor.authorGumus, Selim
dc.contributor.authorKilinc, Fahriye
dc.date.accessioned2024-02-23T14:38:09Z
dc.date.available2024-02-23T14:38:09Z
dc.date.issued2021
dc.departmentNEÜen_US
dc.description.abstractRecent years, we are witnessing a more frequent use of biological agent treatments. Secukinumab (SEC) has been used successfully in the management of psoriasis, psoriatic arthritis, and ankylosing spondylitis. However, the cases of SEC-related lichen planus (LP) are rarely encountered in the literature. Herein, this report presents a case of oral LP induced by SEC in a 33-year-old patient with psoriasis. In addition, this report aims to review the lichen reactions associated with SEC in the literature. In conclusion, LP cases attributable to SEC use are increasingly being observed in new reports. Clinicians who use SEC in their patients should be aware of this side effect and observe patients in terms of cutaneous-mucosal LP. With the introduction of new interleukin-17 (IL-17) inhibitors, the reporting of side effects is crucial for learning whether LP is class side effects or drug-specific side effects for clarifying pathogenesis. Dermatologists and rheumatologists should be aware of the very rare negative effect of IL-17 inhibitors.en_US
dc.identifier.doi10.4274/imj.galenos.2021.95815
dc.identifier.endpage237en_US
dc.identifier.issn2619-9793
dc.identifier.issn2148-094X
dc.identifier.issue3en_US
dc.identifier.startpage235en_US
dc.identifier.urihttps://doi.org/10.4274/imj.galenos.2021.95815
dc.identifier.urihttps://hdl.handle.net/20.500.12452/16381
dc.identifier.volume22en_US
dc.identifier.wosWOS:000683177600013en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherIstanbul Training & Research Hospitalen_US
dc.relation.ispartofIstanbul Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSecukinumaben_US
dc.subjectIl-17 Inhibitorsen_US
dc.subjectLichen Planusen_US
dc.subjectPsoriasisen_US
dc.titleSecukinumab-induced Oral Lichen Planus: A Report of Case and Review of Literatureen_US
dc.typeReview Articleen_US

Dosyalar